metyrapone has been researched along with Hepatoblastoma in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Renner, UD | 1 |
| Piperopoulos, G | 1 |
| Gebhardt, R | 1 |
| Ehninger, G | 1 |
| Zeller, KP | 1 |
1 other study available for metyrapone and Hepatoblastoma
| Article | Year |
|---|---|
The oxidative biotransformation of losoxantrone (CI-941).
Topics: Animals; Anthraquinones; Antineoplastic Agents; Biotransformation; Cells, Cultured; Chromatography, | 2002 |